157 related articles for article (PubMed ID: 38391921)
1. FGF9, a Potent Mitogen, Is a New Ligand for Integrin αvβ3, and the FGF9 Mutant Defective in Integrin Binding Acts as an Antagonist.
Chang CC; Takada YK; Cheng CW; Maekawa Y; Mori S; Takada Y
Cells; 2024 Feb; 13(4):. PubMed ID: 38391921
[TBL] [Abstract][Full Text] [Related]
2. FGF9, a potent mitogen, is a new ligand for integrin αvβ3, and the FGF9 mutant defective in integrin binding acts as an antagonist.
Chang CC; Takada YK; Cheng CW; Maekawa Y; Mori S; Takada Y
bioRxiv; 2023 Dec; ():. PubMed ID: 38076804
[TBL] [Abstract][Full Text] [Related]
3. Direct binding of integrin alphavbeta3 to FGF1 plays a role in FGF1 signaling.
Mori S; Wu CY; Yamaji S; Saegusa J; Shi B; Ma Z; Kuwabara Y; Lam KS; Isseroff RR; Takada YK; Takada Y
J Biol Chem; 2008 Jun; 283(26):18066-75. PubMed ID: 18441324
[TBL] [Abstract][Full Text] [Related]
4. The integrin-binding defective FGF2 mutants potently suppress FGF2 signalling and angiogenesis.
Mori S; Hatori N; Kawaguchi N; Hamada Y; Shih TC; Wu CY; Lam KS; Matsuura N; Yamamoto H; Takada YK; Takada Y
Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28302677
[TBL] [Abstract][Full Text] [Related]
5. A novel fibroblast growth factor-1 (FGF1) mutant that acts as an FGF antagonist.
Yamaji S; Saegusa J; Ieguchi K; Fujita M; Mori S; Takada YK; Takada Y
PLoS One; 2010 Apr; 5(4):e10273. PubMed ID: 20422052
[TBL] [Abstract][Full Text] [Related]
6. A dominant-negative FGF1 mutant (the R50E mutant) suppresses tumorigenesis and angiogenesis.
Mori S; Tran V; Nishikawa K; Kaneda T; Hamada Y; Kawaguchi N; Fujita M; Saegusa J; Takada YK; Matsuura N; Zhao M; Takada Y
PLoS One; 2013; 8(2):e57927. PubMed ID: 23469107
[TBL] [Abstract][Full Text] [Related]
7. Enhanced Expression of Integrin αvβ3 Induced by TGF-β Is Required for the Enhancing Effect of Fibroblast Growth Factor 1 (FGF1) in TGF-β-Induced Epithelial-Mesenchymal Transition (EMT) in Mammary Epithelial Cells.
Mori S; Kodaira M; Ito A; Okazaki M; Kawaguchi N; Hamada Y; Takada Y; Matsuura N
PLoS One; 2015; 10(9):e0137486. PubMed ID: 26334633
[TBL] [Abstract][Full Text] [Related]
8. The direct binding of insulin-like growth factor-1 (IGF-1) to integrin alphavbeta3 is involved in IGF-1 signaling.
Saegusa J; Yamaji S; Ieguchi K; Wu CY; Lam KS; Liu FT; Takada YK; Takada Y
J Biol Chem; 2009 Sep; 284(36):24106-14. PubMed ID: 19578119
[TBL] [Abstract][Full Text] [Related]
9. The chemokine fractalkine can activate integrins without CX3CR1 through direct binding to a ligand-binding site distinct from the classical RGD-binding site.
Fujita M; Takada YK; Takada Y
PLoS One; 2014; 9(5):e96372. PubMed ID: 24789099
[TBL] [Abstract][Full Text] [Related]
10. Integrins αvβ3 and α4β1 act as coreceptors for fractalkine, and the integrin-binding defective mutant of fractalkine is an antagonist of CX3CR1.
Fujita M; Takada YK; Takada Y
J Immunol; 2012 Dec; 189(12):5809-19. PubMed ID: 23125415
[TBL] [Abstract][Full Text] [Related]
11. Low Stability of Integrin-Binding Deficient Mutant of FGF1 Restricts Its Biological Activity.
Szlachcic A; Sochacka M; Czyrek A; Opalinski L; Krowarsch D; Otlewski J; Zakrzewska M
Cells; 2019 Aug; 8(8):. PubMed ID: 31443196
[TBL] [Abstract][Full Text] [Related]
12. Integrin Binding to the Trimeric Interface of CD40L Plays a Critical Role in CD40/CD40L Signaling.
Takada YK; Yu J; Shimoda M; Takada Y
J Immunol; 2019 Sep; 203(5):1383-1391. PubMed ID: 31331973
[TBL] [Abstract][Full Text] [Related]
13. Direct integrin binding to insulin-like growth factor-2 through the C-domain is required for insulin-like growth factor receptor type 1 (IGF1R) signaling.
Cedano Prieto DM; Cheng Y; Chang CC; Yu J; Takada YK; Takada Y
PLoS One; 2017; 12(9):e0184285. PubMed ID: 28873464
[TBL] [Abstract][Full Text] [Related]
14. Soluble CD40L activates soluble and cell-surface integrin αvβ3, α5β1, and α4β1 by binding to the allosteric ligand-binding site (site 2).
Takada YK; Shimoda M; Maverakis E; Felding BH; Cheng RH; Takada Y
J Biol Chem; 2021; 296():100399. PubMed ID: 33571526
[TBL] [Abstract][Full Text] [Related]
15. Virtual Screening of Protein Data Bank via Docking Simulation Identified the Role of Integrins in Growth Factor Signaling, the Allosteric Activation of Integrins, and P-Selectin as a New Integrin Ligand.
Takada Y; Fujita M; Takada YK
Cells; 2023 Sep; 12(18):. PubMed ID: 37759488
[TBL] [Abstract][Full Text] [Related]
16. The binding of monomeric C-reactive protein (mCRP) to Integrins αvβ3 and α4β1 is related to its pro-inflammatory action.
Fujita M; Takada YK; Izumiya Y; Takada Y
PLoS One; 2014; 9(4):e93738. PubMed ID: 24695572
[TBL] [Abstract][Full Text] [Related]
17. Tetraspanin CD9 links junctional adhesion molecule-A to αvβ3 integrin to mediate basic fibroblast growth factor-specific angiogenic signaling.
Peddibhotla SS; Brinkmann BF; Kummer D; Tuncay H; Nakayama M; Adams RH; Gerke V; Ebnet K
Mol Biol Cell; 2013 Apr; 24(7):933-44. PubMed ID: 23389628
[TBL] [Abstract][Full Text] [Related]
18. Direct binding of the EGF-like domain of neuregulin-1 to integrins ({alpha}v{beta}3 and {alpha}6{beta}4) is involved in neuregulin-1/ErbB signaling.
Ieguchi K; Fujita M; Ma Z; Davari P; Taniguchi Y; Sekiguchi K; Wang B; Takada YK; Takada Y
J Biol Chem; 2010 Oct; 285(41):31388-98. PubMed ID: 20682778
[TBL] [Abstract][Full Text] [Related]
19. The heparin-binding domain of VEGF165 directly binds to integrin αvβ3 and plays a critical role in signaling.
Takada YK; Yu J; Ye X; Wu CY; Felding BH; Fujita M; Takada Y
bioRxiv; 2023 Nov; ():. PubMed ID: 38014319
[TBL] [Abstract][Full Text] [Related]
20. The heparin-binding domain of VEGF165 directly binds to integrin αvβ3 and VEGFR2/KDR D1: a potential mechanism of negative regulation of VEGF165 signaling by αvβ3.
Takada YK; Yu J; Ye X; Wu CY; Felding BH; Fujita M; Takada Y
Front Cell Dev Biol; 2024; 12():1347616. PubMed ID: 38803393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
